Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model
Purpose Western diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived...
Gespeichert in:
Veröffentlicht in: | European journal of nutrition 2020-09, Vol.59 (6), p.2617-2629 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2629 |
---|---|
container_issue | 6 |
container_start_page | 2617 |
container_title | European journal of nutrition |
container_volume | 59 |
creator | Muthuramalingam, Karthika Singh, Vineet Choi, Changmin Choi, Seung In Kim, Young Mee Unno, Tatsuya Cho, Moonjae |
description | Purpose
Western diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived (1,3)/(1,6)-β-glucan, a highly soluble dietary fiber, on high-fat diet (HFD)-induced metabolic distress.
Methods
Male C57BL/6 J mice were fed with different diet groups (
n
= 11): control diet, HFD, 3 g/kg or 5 g/kg of β-glucan-incorporated HFD. At the end of experimental study period (12th week), body weight, feces weight and fecal moisture content were observed. Further, colonic motility was measured using activated charcoal meal study. Proteins extracted from liver and intestine tissues were subjected to western blot technique. Paraffin-embedded intestinal tissues were sectioned for histochemical [Periodic acid-Schiff (PAS) and Alcian blue (AB) staining] analysis. Fecal microbiota analysis was performed using MOTHUR bioinformatic software.
Results
β-glucan consumption exhibited anti-obesity property in mice groups fed with HFD. In addition, β-glucan ameliorated HFD-induced hepatic stress, colonic motility and intestinal atrophy (reduction in colon length, goblet cells, and mucosal layer thickness). Further, β-glucan incorporation shifted bacterial community by increasing butyrate-producing bacteria such as
Anaerostipes
,
Coprobacillus
, and
Roseburia
and decreasing reportedly obesity-associated bacteria such as
Parabacteroides
and
Lactococcus.
Conclusion
Altogether, the outcomes of this present pre-clinical animal study show β-glucan to be a promising therapeutic candidate in the treatment of HFD-induced metabolic distress. Further comprehensive research has to be conducted to brace its clinical relevance, reproducibility and efficacy for aiding human health.
Graphical abstract |
doi_str_mv | 10.1007/s00394-019-02110-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2310673532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2431123654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-e9a91e1378a56628091b7078f7e852d9f208bd3d6471c8b3f117196b942c702a3</originalsourceid><addsrcrecordid>eNp9kstu1TAQhiNERUvhBVggS2xaqW49duwkS1SuUqVuYB058STHleMcfKnU1-IReACeCZ-eUiQW3fgif_P_Y81fVW-AnQNjzUVkTHQ1ZdBRxgEYlc-qI6iFooqDfP54Zs1h9TLGG8YYFwpeVIcClKoldEfVrw8Wkw53xPqE4RZ9sqsnOVo_kxM4E6cXZVWn9PdPOrs8an9GNJmyn3OkBoO9RUPi6vLgkGwDDnZNdiR6QWfXoBNGsrHzhk46EVOcqPUmj6VmKa7D6gprbEwBYyTaG6Jd6SKSAT1OdrTauTuSNkjmnMhix7DuDHRpdndDsqwG3avqYNIu4uuH_bj6_unjt8sv9Or689fL91d0rJlIFDvdAYJoWi2V4i3rYGhY004NtpKbbuKsHYwwqm5gbAcxATTQqaGr-dgwrsVxdbLX3Yb1R8aY-sXGEZ3THtccey6AqUZIwQv67j_0Zs3Bl-56LqWStVTQPUnVAqAMS9aF4nuq_D7GgFO_DXYpI-uB9bsc9Psc9CUH_X0OelmK3j5I52FB81jyd_AFEHsglic_Y_jn_YTsHwbQvk0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2431123654</pqid></control><display><type>article</type><title>Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model</title><source>SpringerLink Journals - AutoHoldings</source><creator>Muthuramalingam, Karthika ; Singh, Vineet ; Choi, Changmin ; Choi, Seung In ; Kim, Young Mee ; Unno, Tatsuya ; Cho, Moonjae</creator><creatorcontrib>Muthuramalingam, Karthika ; Singh, Vineet ; Choi, Changmin ; Choi, Seung In ; Kim, Young Mee ; Unno, Tatsuya ; Cho, Moonjae</creatorcontrib><description>Purpose
Western diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived (1,3)/(1,6)-β-glucan, a highly soluble dietary fiber, on high-fat diet (HFD)-induced metabolic distress.
Methods
Male C57BL/6 J mice were fed with different diet groups (
n
= 11): control diet, HFD, 3 g/kg or 5 g/kg of β-glucan-incorporated HFD. At the end of experimental study period (12th week), body weight, feces weight and fecal moisture content were observed. Further, colonic motility was measured using activated charcoal meal study. Proteins extracted from liver and intestine tissues were subjected to western blot technique. Paraffin-embedded intestinal tissues were sectioned for histochemical [Periodic acid-Schiff (PAS) and Alcian blue (AB) staining] analysis. Fecal microbiota analysis was performed using MOTHUR bioinformatic software.
Results
β-glucan consumption exhibited anti-obesity property in mice groups fed with HFD. In addition, β-glucan ameliorated HFD-induced hepatic stress, colonic motility and intestinal atrophy (reduction in colon length, goblet cells, and mucosal layer thickness). Further, β-glucan incorporation shifted bacterial community by increasing butyrate-producing bacteria such as
Anaerostipes
,
Coprobacillus
, and
Roseburia
and decreasing reportedly obesity-associated bacteria such as
Parabacteroides
and
Lactococcus.
Conclusion
Altogether, the outcomes of this present pre-clinical animal study show β-glucan to be a promising therapeutic candidate in the treatment of HFD-induced metabolic distress. Further comprehensive research has to be conducted to brace its clinical relevance, reproducibility and efficacy for aiding human health.
Graphical abstract</description><identifier>ISSN: 1436-6207</identifier><identifier>EISSN: 1436-6215</identifier><identifier>DOI: 10.1007/s00394-019-02110-5</identifier><identifier>PMID: 31664519</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Activated carbon ; Atrophy ; Bacteria ; Body weight ; Carbohydrates ; Charcoal ; Chemistry ; Chemistry and Materials Science ; Colon ; Diet ; Dietary fiber ; Digestive system ; Fecal microflora ; Fungi ; Gastrointestinal tract ; Goblet cells ; High fat diet ; Intestinal microflora ; Intestine ; Metabolic syndrome ; Metabolism ; Microbiota ; Motility ; Mucosa ; Nutrition ; Obesity ; Original Contribution ; Paraffin ; Prebiotics ; Water content ; β-Glucan</subject><ispartof>European journal of nutrition, 2020-09, Vol.59 (6), p.2617-2629</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-e9a91e1378a56628091b7078f7e852d9f208bd3d6471c8b3f117196b942c702a3</citedby><cites>FETCH-LOGICAL-c403t-e9a91e1378a56628091b7078f7e852d9f208bd3d6471c8b3f117196b942c702a3</cites><orcidid>0000-0003-4799-7584</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00394-019-02110-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00394-019-02110-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31664519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muthuramalingam, Karthika</creatorcontrib><creatorcontrib>Singh, Vineet</creatorcontrib><creatorcontrib>Choi, Changmin</creatorcontrib><creatorcontrib>Choi, Seung In</creatorcontrib><creatorcontrib>Kim, Young Mee</creatorcontrib><creatorcontrib>Unno, Tatsuya</creatorcontrib><creatorcontrib>Cho, Moonjae</creatorcontrib><title>Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model</title><title>European journal of nutrition</title><addtitle>Eur J Nutr</addtitle><addtitle>Eur J Nutr</addtitle><description>Purpose
Western diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived (1,3)/(1,6)-β-glucan, a highly soluble dietary fiber, on high-fat diet (HFD)-induced metabolic distress.
Methods
Male C57BL/6 J mice were fed with different diet groups (
n
= 11): control diet, HFD, 3 g/kg or 5 g/kg of β-glucan-incorporated HFD. At the end of experimental study period (12th week), body weight, feces weight and fecal moisture content were observed. Further, colonic motility was measured using activated charcoal meal study. Proteins extracted from liver and intestine tissues were subjected to western blot technique. Paraffin-embedded intestinal tissues were sectioned for histochemical [Periodic acid-Schiff (PAS) and Alcian blue (AB) staining] analysis. Fecal microbiota analysis was performed using MOTHUR bioinformatic software.
Results
β-glucan consumption exhibited anti-obesity property in mice groups fed with HFD. In addition, β-glucan ameliorated HFD-induced hepatic stress, colonic motility and intestinal atrophy (reduction in colon length, goblet cells, and mucosal layer thickness). Further, β-glucan incorporation shifted bacterial community by increasing butyrate-producing bacteria such as
Anaerostipes
,
Coprobacillus
, and
Roseburia
and decreasing reportedly obesity-associated bacteria such as
Parabacteroides
and
Lactococcus.
Conclusion
Altogether, the outcomes of this present pre-clinical animal study show β-glucan to be a promising therapeutic candidate in the treatment of HFD-induced metabolic distress. Further comprehensive research has to be conducted to brace its clinical relevance, reproducibility and efficacy for aiding human health.
Graphical abstract</description><subject>Activated carbon</subject><subject>Atrophy</subject><subject>Bacteria</subject><subject>Body weight</subject><subject>Carbohydrates</subject><subject>Charcoal</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Colon</subject><subject>Diet</subject><subject>Dietary fiber</subject><subject>Digestive system</subject><subject>Fecal microflora</subject><subject>Fungi</subject><subject>Gastrointestinal tract</subject><subject>Goblet cells</subject><subject>High fat diet</subject><subject>Intestinal microflora</subject><subject>Intestine</subject><subject>Metabolic syndrome</subject><subject>Metabolism</subject><subject>Microbiota</subject><subject>Motility</subject><subject>Mucosa</subject><subject>Nutrition</subject><subject>Obesity</subject><subject>Original Contribution</subject><subject>Paraffin</subject><subject>Prebiotics</subject><subject>Water content</subject><subject>β-Glucan</subject><issn>1436-6207</issn><issn>1436-6215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kstu1TAQhiNERUvhBVggS2xaqW49duwkS1SuUqVuYB058STHleMcfKnU1-IReACeCZ-eUiQW3fgif_P_Y81fVW-AnQNjzUVkTHQ1ZdBRxgEYlc-qI6iFooqDfP54Zs1h9TLGG8YYFwpeVIcClKoldEfVrw8Wkw53xPqE4RZ9sqsnOVo_kxM4E6cXZVWn9PdPOrs8an9GNJmyn3OkBoO9RUPi6vLgkGwDDnZNdiR6QWfXoBNGsrHzhk46EVOcqPUmj6VmKa7D6gprbEwBYyTaG6Jd6SKSAT1OdrTauTuSNkjmnMhix7DuDHRpdndDsqwG3avqYNIu4uuH_bj6_unjt8sv9Or689fL91d0rJlIFDvdAYJoWi2V4i3rYGhY004NtpKbbuKsHYwwqm5gbAcxATTQqaGr-dgwrsVxdbLX3Yb1R8aY-sXGEZ3THtccey6AqUZIwQv67j_0Zs3Bl-56LqWStVTQPUnVAqAMS9aF4nuq_D7GgFO_DXYpI-uB9bsc9Psc9CUH_X0OelmK3j5I52FB81jyd_AFEHsglic_Y_jn_YTsHwbQvk0</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Muthuramalingam, Karthika</creator><creator>Singh, Vineet</creator><creator>Choi, Changmin</creator><creator>Choi, Seung In</creator><creator>Kim, Young Mee</creator><creator>Unno, Tatsuya</creator><creator>Cho, Moonjae</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4799-7584</orcidid></search><sort><creationdate>20200901</creationdate><title>Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model</title><author>Muthuramalingam, Karthika ; Singh, Vineet ; Choi, Changmin ; Choi, Seung In ; Kim, Young Mee ; Unno, Tatsuya ; Cho, Moonjae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-e9a91e1378a56628091b7078f7e852d9f208bd3d6471c8b3f117196b942c702a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Activated carbon</topic><topic>Atrophy</topic><topic>Bacteria</topic><topic>Body weight</topic><topic>Carbohydrates</topic><topic>Charcoal</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Colon</topic><topic>Diet</topic><topic>Dietary fiber</topic><topic>Digestive system</topic><topic>Fecal microflora</topic><topic>Fungi</topic><topic>Gastrointestinal tract</topic><topic>Goblet cells</topic><topic>High fat diet</topic><topic>Intestinal microflora</topic><topic>Intestine</topic><topic>Metabolic syndrome</topic><topic>Metabolism</topic><topic>Microbiota</topic><topic>Motility</topic><topic>Mucosa</topic><topic>Nutrition</topic><topic>Obesity</topic><topic>Original Contribution</topic><topic>Paraffin</topic><topic>Prebiotics</topic><topic>Water content</topic><topic>β-Glucan</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muthuramalingam, Karthika</creatorcontrib><creatorcontrib>Singh, Vineet</creatorcontrib><creatorcontrib>Choi, Changmin</creatorcontrib><creatorcontrib>Choi, Seung In</creatorcontrib><creatorcontrib>Kim, Young Mee</creatorcontrib><creatorcontrib>Unno, Tatsuya</creatorcontrib><creatorcontrib>Cho, Moonjae</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Career & Technical Education Database</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muthuramalingam, Karthika</au><au>Singh, Vineet</au><au>Choi, Changmin</au><au>Choi, Seung In</au><au>Kim, Young Mee</au><au>Unno, Tatsuya</au><au>Cho, Moonjae</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model</atitle><jtitle>European journal of nutrition</jtitle><stitle>Eur J Nutr</stitle><addtitle>Eur J Nutr</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>59</volume><issue>6</issue><spage>2617</spage><epage>2629</epage><pages>2617-2629</pages><issn>1436-6207</issn><eissn>1436-6215</eissn><abstract>Purpose
Western diet, rich in carbohydrates and fat, is said to be a major factor underlying metabolic syndrome. Interventions with prebiotics, the key modulators of the gut microbiota, have paramount impact on host-associated metabolic disorders. Herein, we investigated the effect of fungus-derived (1,3)/(1,6)-β-glucan, a highly soluble dietary fiber, on high-fat diet (HFD)-induced metabolic distress.
Methods
Male C57BL/6 J mice were fed with different diet groups (
n
= 11): control diet, HFD, 3 g/kg or 5 g/kg of β-glucan-incorporated HFD. At the end of experimental study period (12th week), body weight, feces weight and fecal moisture content were observed. Further, colonic motility was measured using activated charcoal meal study. Proteins extracted from liver and intestine tissues were subjected to western blot technique. Paraffin-embedded intestinal tissues were sectioned for histochemical [Periodic acid-Schiff (PAS) and Alcian blue (AB) staining] analysis. Fecal microbiota analysis was performed using MOTHUR bioinformatic software.
Results
β-glucan consumption exhibited anti-obesity property in mice groups fed with HFD. In addition, β-glucan ameliorated HFD-induced hepatic stress, colonic motility and intestinal atrophy (reduction in colon length, goblet cells, and mucosal layer thickness). Further, β-glucan incorporation shifted bacterial community by increasing butyrate-producing bacteria such as
Anaerostipes
,
Coprobacillus
, and
Roseburia
and decreasing reportedly obesity-associated bacteria such as
Parabacteroides
and
Lactococcus.
Conclusion
Altogether, the outcomes of this present pre-clinical animal study show β-glucan to be a promising therapeutic candidate in the treatment of HFD-induced metabolic distress. Further comprehensive research has to be conducted to brace its clinical relevance, reproducibility and efficacy for aiding human health.
Graphical abstract</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31664519</pmid><doi>10.1007/s00394-019-02110-5</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-4799-7584</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1436-6207 |
ispartof | European journal of nutrition, 2020-09, Vol.59 (6), p.2617-2629 |
issn | 1436-6207 1436-6215 |
language | eng |
recordid | cdi_proquest_miscellaneous_2310673532 |
source | SpringerLink Journals - AutoHoldings |
subjects | Activated carbon Atrophy Bacteria Body weight Carbohydrates Charcoal Chemistry Chemistry and Materials Science Colon Diet Dietary fiber Digestive system Fecal microflora Fungi Gastrointestinal tract Goblet cells High fat diet Intestinal microflora Intestine Metabolic syndrome Metabolism Microbiota Motility Mucosa Nutrition Obesity Original Contribution Paraffin Prebiotics Water content β-Glucan |
title | Dietary intervention using (1,3)/(1,6)-β-glucan, a fungus-derived soluble prebiotic ameliorates high-fat diet-induced metabolic distress and alters beneficially the gut microbiota in mice model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A46%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dietary%20intervention%20using%20(1,3)/(1,6)-%CE%B2-glucan,%20a%20fungus-derived%20soluble%20prebiotic%20ameliorates%20high-fat%20diet-induced%20metabolic%20distress%20and%20alters%20beneficially%20the%20gut%20microbiota%20in%20mice%20model&rft.jtitle=European%20journal%20of%20nutrition&rft.au=Muthuramalingam,%20Karthika&rft.date=2020-09-01&rft.volume=59&rft.issue=6&rft.spage=2617&rft.epage=2629&rft.pages=2617-2629&rft.issn=1436-6207&rft.eissn=1436-6215&rft_id=info:doi/10.1007/s00394-019-02110-5&rft_dat=%3Cproquest_cross%3E2431123654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2431123654&rft_id=info:pmid/31664519&rfr_iscdi=true |